Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2000
06/22/2000WO2000035472A2 Cytokine combination therapy
06/22/2000WO2000035471A1 Soluble haemopoietin receptor nr6 (clf-1) and uses thereof
06/22/2000WO2000035470A1 Human mad proteins and uses thereof
06/22/2000WO2000035469A2 hCG THERAPY FOR THE TREATMENT OF BREAST CANCER
06/22/2000WO2000035434A2 Compositions and methods for the treatment of anorectal disorders
06/22/2000WO2000035409A2 Hiv-i fusion inhibition compounds
06/22/2000WO2000035408A2 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
06/22/2000WO2000035407A2 Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
06/22/2000WO2000026362A3 Proteins of the stomatin family and their use as target proteins for pain therapy
06/22/2000WO2000023955A8 Virus-like particles for the induction of autoantibodies
06/22/2000WO2000017239A8 Purification of fibrinogen from fluids by precipitation and hydrophobic chromatography
06/22/2000WO2000015244A3 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
06/22/2000WO2000014198A9 Isolation of human pemt2 gene and methods for diagnosing and treating liver disorders
06/22/2000WO2000014106A9 Novel bag proteins and nucleic acid molecules encoding them
06/22/2000WO2000012709A3 Phelix: a testis-specific protein expressed in cancer
06/22/2000WO2000012703A3 Protein transport-associated molecules
06/22/2000WO2000012544A3 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
06/22/2000WO2000012046A3 Pkdl nucleic acids, polypeptides, and diagnostic and therapeutic methods
06/22/2000WO2000012018A9 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers or covering structures
06/22/2000WO2000011168A3 Genes that regulate hematopoietic blood forming stem cells and uses thereof
06/22/2000WO2000011165A9 ROLE OF HUMAN KIS (hKIS) AS AN INHIBITORY KINASE OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P27. COMPOSITIONS, METHODS AND USES THEREOF TO CONTROL CELL PROLIFERATION
06/22/2000WO2000011033A3 Expression and export of angiostatin and endostatin as immunofusins
06/22/2000WO2000011029A3 Novel anti-diabetic peptides
06/22/2000WO2000010599A3 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
06/22/2000WO2000009695A3 Drug targets in candida albicans
06/22/2000WO2000009667A9 Calcineurin-dependent control of skeletal muscle fiber type
06/22/2000WO2000007624A3 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix
06/22/2000WO2000006759A3 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same
06/22/2000WO2000004135A3 Human scad-related molecules, scrm-1 and scrm-2
06/22/2000WO2000002908A3 Inhibition of alopecia
06/22/2000WO1999065928A8 Polynucleotide population isolated from non-metastatic and metastatic breast tumor tissues
06/22/2000WO1999059615A9 Hybrid polypeptides with enhanced pharmacokinetic properties
06/22/2000WO1999054707A3 Fetal testing for prediction of low birth weight
06/22/2000WO1999054462A3 Bacterial ycfb polypeptide family
06/22/2000CA2727746A1 Quinolone vitronectin receptor antagonist pharmaceuticals
06/22/2000CA2407803A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/22/2000CA2362423A1 47 human secreted proteins
06/22/2000CA2355971A1 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
06/22/2000CA2355901A1 Plant cell cycle genes and uses thereof
06/22/2000CA2355870A1 Reagents and methods useful for detecting diseases of the breast
06/22/2000CA2355818A1 Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators
06/22/2000CA2355607A1 Anti-ccr5 antibody
06/22/2000CA2355363A1 Prostacyclin-stimulating factor-2
06/22/2000CA2355287A1 Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
06/22/2000CA2355270A1 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
06/22/2000CA2355039A1 Pancreatic polypeptide zsig66
06/22/2000CA2354543A1 Compositions and methods for the treatment of anorectal disorders
06/22/2000CA2354539A1 A method for the high level expression of active lymphotoxin-.beta. receptor immunoglobulin chimeric proteins and their purification
06/22/2000CA2354456A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354451A1 Halovir, an antiviral marine natural product, and derivatives thereof
06/22/2000CA2354422A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354156A1 Compositions and methods for therapy and diagnosis of ovarian cancer
06/22/2000CA2354147A1 Methods of immunosuppression
06/22/2000CA2354056A1 Cyclic peptide antifungal agents
06/22/2000CA2354055A1 Cyclic peptide antifungal agents having a sugar substituent
06/22/2000CA2353997A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp
06/22/2000CA2353866A1 Treatment of papillomavirus infections
06/22/2000CA2352570A1 Methods and compositions for treating disorders involving excitotoxicity
06/22/2000CA2351726A1 Hcg therapy for the treatment of breast cancer
06/22/2000CA2349501A1 Quinolone vitronectin receptor antagonist pharmaceuticals
06/22/2000CA2290219A1 Leptospira vaccine antigens for the prevention of leptospirosis
06/21/2000EP1010758A2 An expression system for producing recombinant human erythropoietin, a method for purifying the secreted human erythropoietin and uses thereof
06/21/2000EP1010705A1 Novel cyclic tetrapeptide derivatives and medicinal use thereof
06/21/2000EP1010434A2 Inhibitor of Helicobacter pylori colonization
06/21/2000EP1010433A1 Remedies for diseases caused by insulin resistance
06/21/2000EP1010432A1 Remedies for diabetes
06/21/2000EP1010431A2 Botulinum toxins for treating pain associated with muscle spasms
06/21/2000EP1010430A1 Preventives and ameliorating agents for periodontosis
06/21/2000EP1009860A1 Antisense oligonucleotide inhibition of ras
06/21/2000EP1009859A1 Lyme disease vaccines
06/21/2000EP1009854A1 A method of treating cancer
06/21/2000EP1009847A1 Conjugates that contain the homeodomain of antennapedia
06/21/2000EP1009831A2 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
06/21/2000EP1009830A1 Genetic engineering of cells to enhance healing and tissue regeneration
06/21/2000EP1009829A1 Adipocyte-specific protein homologs
06/21/2000EP1009828A1 New human g-protein coupled receptor
06/21/2000EP1009826A1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof
06/21/2000EP1009824A1 COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-kappaB ACTIVATION
06/21/2000EP1009823A1 Human papilloma virus inhibition by antisense oligonucleotides
06/21/2000EP1009822A1 Antisense treatment of pulmonary hypertension
06/21/2000EP1009817A1 Rtd receptor
06/21/2000EP1009811A2 New tissue-specific calpaines, their production and their use
06/21/2000EP1009806A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
06/21/2000EP1009804A1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
06/21/2000EP1009772A1 Monoclonal antibodies that bind testosterone
06/21/2000EP1009771A1 Peptides which elicit cytotoxic t cellular immunity
06/21/2000EP1009770A1 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
06/21/2000EP1009769A1 N-terminal modifications of rantes and methods of use
06/21/2000EP1009768A1 Persephin and related growth factors
06/21/2000EP1009767A1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
06/21/2000EP1009765A1 EPO PRIMARY RESPONSE GENE, EPRG3Spt
06/21/2000EP1009763A1 Synthetic hepatitis c genes
06/21/2000EP1009762A2 Lipocalin homologs
06/21/2000EP1009761A1 Biomolecules comprising an elastomeric peptide
06/21/2000EP1009760A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
06/21/2000EP1009759A1 Carbohydrate crosslinked glycoprotein crystals
06/21/2000EP1009758A1 Meta-benzamidine derivatives as serine protease inhibitors
06/21/2000EP1009757A1 Modular protein libraries and methods of preparation
06/21/2000EP1009756A1 RECOMBINANT HUMAN IgA-J. CHAIN DIMER
06/21/2000EP1009753A1 Hypoxia-regulated genes
1 ... 2378 2379 2380 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 ... 3163